|
Alcohol
dehydrogenase- Mutein2A65D
Optically
active compounds that have the potential to offer improvements over
existing therapies with respect to efficiency, side effect profile,
dosage forms, or in some cases, the opportunity for additional
indications are today employed in many areas,
where a high enantiomeric purity is required.
A
novel and improved oxidoreductase catalyzing the reduction of a
variety of carbonyl compounds especially keto esters has been
created by X-Zyme with the help of directed evolution, shows a high
enantioselectivity and a very broad substrate range: aliphatic,
cyclic and aromatic ketones, diketones and keto acid esters,
different compounds can be converted in high enantiomeric purity.
X-Zyme
Biotechnology also provides access to unique libraries of
oxidoreductases variants and conducts the screening of these
libraries for the selection of biocatalysts with desired properties.
|